Willis Towers Watson (WTW) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Achieved 6% organic revenue growth and 5% total revenue growth year-over-year in Q2 2024, with revenue reaching $2.3 billion.
Adjusted diluted EPS rose 24% to $2.55; diluted EPS increased 55% to $1.36; net income grew 48%-50% to $141-$142 million.
Transformation program delivered $24 million incremental annualized savings in Q2, totaling $394 million, with a target of $450 million by year-end 2024.
Returned $290 million to shareholders in Q2 via $200 million in share repurchases and $90 million in dividends.
Strategic hires, technology modernization, and operational efficiency initiatives continued to drive growth and margin expansion.
Financial highlights
Adjusted operating margin for Q2 was 17.0%, up 240 basis points year-over-year.
Adjusted EBITDA for Q2 was $466 million (20.6% margin), up from $411 million (19.0% margin) in Q2 2023.
Free cash flow for the first half was $361 million, up from $350 million in the prior year.
Net cash from operating activities was $431 million for Q2, flat year-over-year.
Returned $290 million to shareholders in Q2 through share repurchases and dividends.
Outlook and guidance
Raised 2024 guidance: adjusted operating margin now 23.0%-23.5%, adjusted EPS $16.00-$17.00, and transformation savings target increased to $450 million.
Revenue target reaffirmed at $9.9+ billion for 2024, with mid-single-digit organic growth expected.
Free cash flow margin target of 16%+ remains a longer-term goal, with improvement expected as transformation spend abates.
Share repurchases expected to total ~$750 million in 2024, subject to market conditions.
Management expects sufficient liquidity for the next twelve months, with no mandatory debt repayments and a fully available $1.5 billion revolving credit facility.
Latest events from Willis Towers Watson
- 5% organic growth and margin gains offset TRANZACT sale, driving higher net income.WTW
Q1 20258 Jul 2026 - 5% organic growth, margin gains, and $473M in savings set up for continued strong performance.WTW
Q4 20248 Jul 2026 - Organic growth and margin expansion offset divestiture impacts, boosting adjusted EPS and cash flow.WTW
Q4 20258 Jul 2026 - Q2 2025 saw 5% organic growth, margin expansion, and net income up 135% year-over-year.WTW
Q2 20258 Jul 2026 - Revenue up 8%, adjusted EPS up 19%, with margin expansion and $300M in buybacks.WTW
Q1 202630 Apr 2026 - Six major proposals, board refreshment, strong performance, and enhanced risk oversight highlighted.WTW
Proxy filing27 Mar 2026 - Key votes include director elections, auditor ratification, and share plan amendments.WTW
Proxy filing27 Mar 2026 - Q3 saw 6% revenue growth, margin gains, and a $1.67B loss from TRANZACT sale charges.WTW
Q3 202417 Jan 2026 - Sustained organic growth and margin expansion driven by innovation, efficiency, and portfolio optimization.WTW
CMD 202412 Jan 2026